Commonwealth Equity Services’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21.5M | Sell |
109,247
-5,116
| -4% | -$986K | 0.03% | 539 |
|
|
2025
Q4 | $21M | Buy |
114,363
+18,426
| +19% | +$3.23M | 0.03% | 539 |
|
|
2025
Q3 | $14.7M | Sell |
95,937
-4,337
| -4% | -$656K | 0.02% | 710 |
|
|
2025
Q2 | $14M | Sell |
100,274
-3,648
| -4% | -$511K | 0.02% | 724 |
|
|
2025
Q1 | $15.3M | Buy |
103,922
+7,705
| +8% | +$1.11M | 0.02% | 667 |
|
|
2024
Q4 | $12.6M | Sell |
96,217
-445
| -0.5% | -$62.3K | 0.02% | 710 |
|
|
2024
Q3 | $15.1M | Sell |
96,662
-7,871
| -8% | -$1.27M | 0.02% | 635 |
|
|
2024
Q2 | $16.3M | Buy |
104,533
+2,846
| +3% | +$428K | 0.03% | 589 |
|
|
2024
Q1 | $13.8M | Buy |
101,687
+9,901
| +11% | +$1.31M | 0.02% | 646 |
|
|
2023
Q4 | $12.4M | Buy |
91,786
+1,874
| +2% | +$244K | 0.02% | 640 |
|
|
2023
Q3 | $12.2M | Buy |
89,912
+105
| +0.1% | +$14.3K | 0.03% | 595 |
|
|
2023
Q2 | $12.9M | Buy |
89,807
+4,556
| +5% | +$670K | 0.03% | 585 |
|
|
2023
Q1 | $11.8K | Buy |
85,251
+1,262
| +2% | +$170K | 0.02% | 594 |
|
|
2022
Q4 | $11.4M | Buy |
83,989
+2,995
| +4% | +$376K | 0.03% | 578 |
|
|
2022
Q3 | $8.88M | Sell |
80,994
-2,167
| -3% | -$275K | 0.02% | 625 |
|
|
2022
Q2 | $11M | Buy |
83,161
+222
| +0.3% | +$29.1K | 0.03% | 544 |
|
|
2022
Q1 | $11M | Buy |
82,939
+2,741
| +3% | +$329K | 0.03% | 586 |
|
|
2021
Q4 | $9.34M | Sell |
80,198
-615
| -0.8% | -$72.4K | 0.02% | 627 |
|
|
2021
Q3 | $9.71M | Buy |
80,813
+9,391
| +13% | +$1.09M | 0.02% | 584 |
|
|
2021
Q2 | $8.56M | Sell |
71,422
-7,012
| -9% | -$769K | 0.02% | 616 |
|
|
2021
Q1 | $7.8M | Sell |
78,434
-13,740
| -15% | -$1.38M | 0.02% | 592 |
|
|
2020
Q4 | $9.21M | Sell |
92,174
-897
| -1% | -$95K | 0.03% | 499 |
|
|
2020
Q3 | $10.2M | Buy |
93,071
+18,945
| +26% | +$2.11M | 0.03% | 425 |
|
|
2020
Q2 | $7.84M | Buy |
74,126
+4,661
| +7% | +$481K | 0.03% | 481 |
|
|
2020
Q1 | $6.2M | Sell |
69,465
-1,995
| -3% | -$188K | 0.03% | 480 |
|
|
2019
Q4 | $7.13M | Buy |
71,460
+637
| +0.9% | +$60K | 0.03% | 513 |
|
|
2019
Q3 | $6.31M | Buy |
70,823
+2,210
| +3% | +$192K | 0.03% | 519 |
|
|
2019
Q2 | $5.66M | Buy |
68,613
+5,467
| +9% | +$429K | 0.03% | 525 |
|
|
2019
Q1 | $5.11M | Buy |
63,146
+1,005
| +2% | +$79.2K | 0.02% | 551 |
|
|
2018
Q4 | $4.72M | Buy |
62,141
+193
| +0.3% | +$15.1K | 0.03% | 514 |
|
|
2018
Q3 | $4.9M | Buy |
61,948
+1,730
| +3% | +$131K | 0.02% | 536 |
|
|
2018
Q2 | $4.23M | Sell |
60,218
-2,214
| -4% | -$159K | 0.02% | 568 |
|
|
2018
Q1 | $4.37M | Buy |
62,432
+2,058
| +3% | +$143K | 0.02% | 526 |
|
|
2017
Q4 | $4.19M | Sell |
60,374
-477
| -0.8% | -$32.2K | 0.02% | 533 |
|
|
2017
Q3 | $4.12M | Buy |
60,851
+2,770
| +5% | +$175K | 0.02% | 514 |
|
|
2017
Q2 | $3.96M | Sell |
58,081
-5,209
| -8% | -$340K | 0.03% | 511 |
|
|
2017
Q1 | $3.94M | Buy |
63,290
+3,416
| +6% | +$199K | 0.03% | 499 |
|
|
2016
Q4 | $3.27M | Buy |
59,874
+16,058
| +37% | +$912K | 0.02% | 523 |
|
|
2016
Q3 | $2.88M | Buy |
43,816
+1,021
| +2% | +$66.7K | 0.02% | 534 |
|
|
2016
Q2 | $2.58M | Sell |
42,795
-1,332
| -3% | -$77.4K | 0.02% | 550 |
|
|
2016
Q1 | $2.48M | Buy |
44,127
+2,693
| +6% | +$162K | 0.02% | 549 |
|
|
2015
Q4 | $2.81M | Buy |
41,434
+1,833
| +5% | +$120K | 0.03% | 510 |
|
|
2015
Q3 | $2.52M | Buy |
39,601
+1,124
| +3% | +$73.9K | 0.03% | 509 |
|
|
2015
Q2 | $2.45M | Sell |
38,477
-298
| -0.8% | -$20.4K | 0.02% | 553 |
|
|
2015
Q1 | $2.65M | Buy |
38,775
+659
| +2% | +$45.8K | 0.03% | 514 |
|
|
2014
Q4 | $2.68M | Sell |
38,116
-1,773
| -4% | -$127K | 0.03% | 470 |
|
|
2014
Q3 | $2.85M | Buy |
39,889
+1,553
| +4% | +$114K | 0.03% | 433 |
|
|
2014
Q2 | $2.85M | Sell |
38,336
-9,129
| -19% | -$660K | 0.03% | 433 |
|
|
2014
Q1 | $3.08M | Buy |
47,465
+3,880
| +9% | +$251K | 0.04% | 365 |
|
|
2013
Q4 | $2.59M | Buy |
43,585
+2,078
| +5% | +$113K | 0.04% | 400 |
|
|
2013
Q3 | $2.15M | Buy |
41,507
+5,513
| +15% | +$277K | 0.04% | 430 |
|
|
2013
Q2 | $1.7M | Buy |
+35,994
| New | +$1.83M | 0.03% | 472 |
|
Other funds holding AZN
IA
VCM
VAM
Commonwealth Equity Services's AZN Position: Q1 2026 in Review
Commonwealth Equity Services reduced its AstraZeneca (AZN) stake by 4.5% in Q1 2026, selling an estimated $986K and leaving 109,247 shares worth $21.5M. The position accounts for 0.03% of the portfolio, ranked #539.
Commonwealth Equity Services first reported a position in AZN in Q2 2013 and has held it in 52 quarters since. 1,378 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Commonwealth Equity Services held 109,247 shares of AstraZeneca worth $21.5M as of Q1 2026.
- Commonwealth Equity Services sold 5,116 AstraZeneca shares in Q1 2026, an estimated $986K.
- AstraZeneca made up 0.03% of Commonwealth Equity Services's portfolio in Q1 2026, its #539 holding.
- Commonwealth Equity Services first reported a position in AstraZeneca in Q2 2013 and has held it in 52 quarters since.
- 1,378 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Commonwealth Equity Services's 13F filing for Q1 2026, filed 27 Apr 2026.